Are diabetic metabolic compensation and CA19.9 really correlated?

G. Banfi, A. Ardemagni, S. Bravi, M. Pacchioni, P. Bonini

Research output: Contribution to journalArticlepeer-review

Abstract

Diabetes has been claimed to be a risk factor for pancreatic carcinoma, but it is probably a consequence of gland invasion from the neoplastic tissue. A link between diabetes and pancreatic cat-cinema was suggested by means of biochemical markers of the diseases, namely glycated hemoglobin and CA19.9. Moreover, CA19.9 was proposed as a sensitive and useful marker of the severity of exocrine damage in diabetes, since the mucin decreased when metabolic compensation improved. We examined 64 diabetic patients (36 insulin dependent, 16 non insulin dependent, 12 treated with diet) by measuring CA19.9 using two different immuno-metric methods and glycemia and glycated hemoglobin. We observed that a correlation between CA19.9 and biochemical markers of metabolic compensation of diabetes was inexistent and no differences between insulin dependent and non insulin dependent patients were found. A high concentration of CA19.9 in a diabetic patient should be interpreted and evaluated in the same manner as for a non diabetic patient.

Original languageEnglish
Pages (from-to)207-210
Number of pages4
JournalInternational Journal of Biological Markers
Volume11
Issue number4
Publication statusPublished - Oct 1996

Keywords

  • CA19.9
  • Diabetes
  • Glycated hemoglobin
  • Pancreatic carcinoma

ASJC Scopus subject areas

  • Immunology
  • Biochemistry

Fingerprint

Dive into the research topics of 'Are diabetic metabolic compensation and CA19.9 really correlated?'. Together they form a unique fingerprint.

Cite this